News
Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...
Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic ...
I reviewed the less-than-stellar history of weight loss medications as a prelude to a discussion of the hottest meds on the ...
Currently, there is only one U.S. government-approved treatment available for fatty liver disease, Rezdiffra (resmetirom), ...
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...
While Berberine is touted as a natural alternative to Ozempic, its AMPK modulation differs from GLP-1 pathways, highlighting ...
T1D Fund Joins Financing Syndicate - - Proceeds to Fund Remainder of Phase 2a 'ZONE' Trial and Nonclinical Development of a Once-Weekly V ...
Protein is a cornerstone nutrient for maintaining overall health, but its significance becomes especially prominent for those ...
In 2021, 529 million people were living with diabetes worldwide, and an estimated 1·31 billion individuals are projected to ...
Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results